Background The overall incidence of male breast cancer is around 1% of all breast cancers
and is on the rise. In this review we aim to present various aspects of male breast cancer …

Purpose Because of its rarity, male breast cancer is often compared with female breast
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …

Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …

Purpose: Male breast cancer is rare, and its genomic landscape has yet to be fully
characterized. Lacking studies in men, treatment of males with breast cancer is extrapolated …

Diagnosis and treatment modalities for female breast cancer have developed spectacularly
in recent years. Unfortunately, this is not the case for male breast cancer. Because the …

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center,
Houston, TX, USA and anastrozole was closed due to poor accrual. Further research is …

Male breast cancer (MBC) is a rare entity, underrepresented in population studies and
clinical trials, resulting in management of MBC to be informed by current research on female …

Male breast cancer has always been shadowed by the attention received by its other half of
the coin; female breast cancer. It is widely known to be 1% of all breast cancer, constituting …

Male breast cancer (MBC) is a rare disease with an older average age of presentation than
in women. Predisposing factors include increased exposure to oestrogen and being a …

Simple Summary Male breast cancer (MBC) is a rare disease. Genetic factors predispose to
male breast cancer. Germline and/or genetic and/or epigenetic alterations at the somatic …